Aster Dm Healthcare Share Price
Sector: Healthcare Facilities
497.10 +4.55 (0.92%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
493.05
Today’s High
505
52 Week Low
312.25
52 Week High
534
500.30 +7.55 (1.53%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
493.05
Today’s High
503.45
52 Week Low
311.10
52 Week High
534.80
Key Metrics
- Market Cap (In Cr) 24830.8
- Beta 1.19
- Div. Yield (%) 1.2
- P/B 5.46
- TTM P/E 96.99
- Sector P/E 22.74
- Open Price 498.95
- Prev Close 492.55
Aster Dm Healthcare Analysis
Price Analysis
-
1 Week2.75%
-
3 Months-0.83%
-
6 Month19.06%
-
YTD-2.66%
-
1 Year36.69%
Risk Meter
- 33% Low risk
- 33% Moderate risk
- 33% Balanced Risk
- 33% High risk
- 33% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 5
- 5
- 5
- 3
- Buy
- 3
- 3
- 3
- 4
- Hold
- 0.00
- 0.00
- 0.00
- 1
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 8
- 8
- 8
- 8
Aster Dm Healthcare News
These 5 small-cap stocks have higher yields than bank FD, PPF interest rate
2 min read . 08 Apr 2025Top stock picks: Market experts recommend these stocks to buy today
2 min read . 01 Apr 2025As the weight of promoter pledge lifts, Aster DM is free to grow again
6 min read . 19 Mar 2025Aster Dm Healthcare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 3698.9
- Selling/ General/ Admin Expenses Total
- 1252.62
- Depreciation/ Amortization
- 219.97
- Other Operating Expenses Total
- 51.67
- Total Operating Expense
- 3340.69
- Operating Income
- 358.21
- Net Income Before Taxes
- 261.19
- Net Income
- 129.28
- Diluted Normalized EPS
- 2.46
- Period
- 2024
- Total Assets
- 17991.31
- Total Liabilities
- 13431.52
- Total Equity
- 4559.79
- Tangible Book Valueper Share Common Eq
- 85.67
- Period
- 2024
- Cashfrom Operating Activities
- 157.81
- Cashfrom Investing Activities
- -884.65
- Cashfrom Financing Activities
- 1052.83
- Net Changein Cash
- 332.39
- Period
- 2023
- Total Revenue
- 2994.05
- Selling/ General/ Admin Expenses Total
- 1003.09
- Depreciation/ Amortization
- 192.04
- Other Operating Expenses Total
- 49.71
- Total Operating Expense
- 2737.01
- Operating Income
- 257.04
- Net Income Before Taxes
- 195.46
- Net Income
- 424.91
- Diluted Normalized EPS
- 2.19
- Period
- 2023
- Total Assets
- 14881.2
- Total Liabilities
- 10433.13
- Total Equity
- 4448.07
- Tangible Book Valueper Share Common Eq
- 58.72
- Period
- 2023
- Cashfrom Operating Activities
- 1833.98
- Cashfrom Investing Activities
- -971.88
- Cashfrom Financing Activities
- -817.39
- Net Changein Cash
- 65.74
- Period
- 2022
- Total Revenue
- 10253.28
- Selling/ General/ Admin Expenses Total
- 4491.38
- Depreciation/ Amortization
- 640.58
- Other Operating Expenses Total
- 450.57
- Total Operating Expense
- 9409.35
- Operating Income
- 843.93
- Net Income Before Taxes
- 636.85
- Net Income
- 525.99
- Diluted Normalized EPS
- 10.57
- Period
- 2022
- Total Assets
- 12546.24
- Total Liabilities
- 8592.83
- Total Equity
- 3953.41
- Tangible Book Valueper Share Common Eq
- 52.04
- Period
- 2022
- Cashfrom Operating Activities
- 1313.46
- Cashfrom Investing Activities
- -570.48
- Cashfrom Financing Activities
- -685.42
- Net Changein Cash
- 64.78
- Period
- 2021
- Total Revenue
- 8608.43
- Selling/ General/ Admin Expenses Total
- 3807.17
- Depreciation/ Amortization
- 617.57
- Other Operating Expenses Total
- 436.12
- Total Operating Expense
- 8160.92
- Operating Income
- 447.51
- Net Income Before Taxes
- 205.05
- Net Income
- 147.74
- Diluted Normalized EPS
- 2.97
- Period
- 2021
- Total Assets
- 11643.46
- Total Liabilities
- 8271
- Total Equity
- 3372.46
- Tangible Book Valueper Share Common Eq
- 41.65
- Period
- 2021
- Cashfrom Operating Activities
- 1569.12
- Cashfrom Investing Activities
- -330.3
- Cashfrom Financing Activities
- -1116.13
- Net Changein Cash
- 119.9
- Period
- 2020
- Total Revenue
- 8651.88
- Selling/ General/ Admin Expenses Total
- 3849.46
- Depreciation/ Amortization
- 585.94
- Other Operating Expenses Total
- 204.31
- Total Operating Expense
- 7999.28
- Operating Income
- 652.6
- Net Income Before Taxes
- 330.04
- Net Income
- 276.61
- Diluted Normalized EPS
- 5.97
- Period
- 2020
- Total Assets
- 12437.84
- Total Liabilities
- 9165.7
- Total Equity
- 3272.14
- Tangible Book Valueper Share Common Eq
- 39.78
- Period
- 2020
- Cashfrom Operating Activities
- 1223.25
- Cashfrom Investing Activities
- -667.28
- Cashfrom Financing Activities
- -674.8
- Net Changein Cash
- -109.92
- Period
- 2019
- Total Revenue
- 7962.71
- Selling/ General/ Admin Expenses Total
- 3525.97
- Depreciation/ Amortization
- 306.47
- Other Operating Expenses Total
- 449.9
- Total Operating Expense
- 7405.45
- Operating Income
- 557.26
- Net Income Before Taxes
- 410.25
- Net Income
- 333.11
- Diluted Normalized EPS
- 6.62
- Period
- 2019
- Total Assets
- 8936.41
- Total Liabilities
- 5722.65
- Total Equity
- 3213.76
- Tangible Book Valueper Share Common Eq
- 44.48
- Period
- 2019
- Cashfrom Operating Activities
- 583.55
- Cashfrom Investing Activities
- -691.54
- Cashfrom Financing Activities
- 134.42
- Net Changein Cash
- 32.93
- Period
- 2018
- Total Revenue
- 6721.16
- Selling/ General/ Admin Expenses Total
- 3232.94
- Depreciation/ Amortization
- 297.74
- Other Operating Expenses Total
- 209.56
- Total Operating Expense
- 6271
- Operating Income
- 450.16
- Net Income Before Taxes
- 307.76
- Net Income
- 268.88
- Diluted Normalized EPS
- 3.18
- Period
- 2018
- Total Assets
- 7484.24
- Total Liabilities
- 4652.14
- Total Equity
- 2832.09
- Tangible Book Valueper Share Common Eq
- 40.76
- Period
- 2018
- Cashfrom Operating Activities
- 537.35
- Cashfrom Investing Activities
- -522.53
- Cashfrom Financing Activities
- 45.68
- Net Changein Cash
- 60.63
- Period
- 2024-12-31
- Total Revenue
- 1049.81
- Selling/ General/ Admin Expenses Total
- 193.64
- Depreciation/ Amortization
- 62.21
- Other Operating Expenses Total
- 190.59
- Total Operating Expense
- 946.56
- Operating Income
- 103.25
- Net Income Before Taxes
- 101.88
- Net Income
- 56.79
- Diluted Normalized EPS
- 1.44
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 1086.44
- Selling/ General/ Admin Expenses Total
- 193.35
- Depreciation/ Amortization
- 62.27
- Other Operating Expenses Total
- 199.98
- Total Operating Expense
- 928.97
- Operating Income
- 157.47
- Net Income Before Taxes
- 158.65
- Net Income
- 96.84
- Diluted Normalized EPS
- 1.78
- Period
- 2024-09-30
- Total Assets
- 6687.6
- Total Liabilities
- 3252.13
- Total Equity
- 3435.47
- Tangible Book Valueper Share Common Eq
- 63.05
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 201.59
- Cashfrom Investing Activities
- 6773.52
- Cashfrom Financing Activities
- -6142.7
- Net Changein Cash
- 832.34
- Period
- 2024-06-30
- Total Revenue
- 1001.87
- Selling/ General/ Admin Expenses Total
- 190.44
- Depreciation/ Amortization
- 60.41
- Other Operating Expenses Total
- 193.37
- Total Operating Expense
- 898.74
- Operating Income
- 103.13
- Net Income Before Taxes
- 119.99
- Net Income
- 5145.18
- Diluted Normalized EPS
- 1.48
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 3698.9
- Selling/ General/ Admin Expenses Total
- 675.93
- Depreciation/ Amortization
- 219.97
- Other Operating Expenses Total
- 713.53
- Total Operating Expense
- 3340.92
- Operating Income
- 357.98
- Net Income Before Taxes
- 261.19
- Net Income
- 129.28
- Diluted Normalized EPS
- 2.46
- Period
- 2024-03-31
- Total Assets
- 17991.31
- Total Liabilities
- 13431.52
- Total Equity
- 4559.79
- Tangible Book Valueper Share Common Eq
- 85.67
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 157.81
- Cashfrom Investing Activities
- -884.65
- Cashfrom Financing Activities
- 1052.83
- Net Changein Cash
- 332.39
- Period
- 2023-12-31
- Total Revenue
- 954.67
- Selling/ General/ Admin Expenses Total
- 177.25
- Depreciation/ Amortization
- 56.51
- Other Operating Expenses Total
- 183.97
- Total Operating Expense
- 859.48
- Operating Income
- 95.19
- Net Income Before Taxes
- 76.61
- Net Income
- 179.21
- Diluted Normalized EPS
- 0.71
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 929.43
- Selling/ General/ Admin Expenses Total
- 172.12
- Depreciation/ Amortization
- 54.42
- Other Operating Expenses Total
- 177.41
- Total Operating Expense
- 838.85
- Operating Income
- 90.58
- Net Income Before Taxes
- 61.27
- Net Income
- -30.8
- Diluted Normalized EPS
- 0.75
- Period
- 2023-09-30
- Total Assets
- 15708.35
- Total Liabilities
- 11335.32
- Total Equity
- 4373.03
- Tangible Book Valueper Share Common Eq
- 56.61
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 818.16
- Cashfrom Investing Activities
- -419.49
- Cashfrom Financing Activities
- -341.28
- Net Changein Cash
- 61.74
- Period
- 2023-06-30
- Total Revenue
- 3215.37
- Selling/ General/ Admin Expenses Total
- 1090.8
- Depreciation/ Amortization
- 217.46
- Other Operating Expenses Total
- 484.38
- Total Operating Expense
- 3045.12
- Operating Income
- 170.25
- Net Income Before Taxes
- 73.25
- Net Income
- 4.9
- Diluted Normalized EPS
- 0.1
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 3262.32
- Selling/ General/ Admin Expenses Total
- 987.56
- Depreciation/ Amortization
- 218.6
- Other Operating Expenses Total
- 549.5
- Total Operating Expense
- 2974.84
- Operating Income
- 287.48
- Net Income Before Taxes
- 205.78
- Net Income
- 170.77
- Diluted Normalized EPS
- 3.43
- Period
- 2023-03-31
- Total Assets
- 14881.2
- Total Liabilities
- 10433.13
- Total Equity
- 4448.07
- Tangible Book Valueper Share Common Eq
- 58.72
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 1833.98
- Cashfrom Investing Activities
- -971.88
- Cashfrom Financing Activities
- -817.39
- Net Changein Cash
- 65.74
- Period
- 2022-12-31
- Total Revenue
- 3192.14
- Selling/ General/ Admin Expenses Total
- 1042.99
- Depreciation/ Amortization
- 197.51
- Other Operating Expenses Total
- 481.28
- Total Operating Expense
- 2941.97
- Operating Income
- 250.17
- Net Income Before Taxes
- 173.44
- Net Income
- 139.39
- Diluted Normalized EPS
- 2.8
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Aster Dm Healthcare Technical
Moving Average
SMA
- 5 Day486.05
- 10 Day481.53
- 20 Day457.73
- 50 Day444.37
- 100 Day467.33
- 300 Day429.33
Aster Dm Healthcare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Narayana Hrudayalaya
- 1700.5
- 10.7
- 0.63
- 1758.4
- 1087.8
- 34818.99
- Global Health
- 1267.25
- 38.55
- 3.14
- 1510.1
- 936.05
- 34036.74
- Aster Dm Healthcare
- 497.1
- 4.55
- 0.92
- 534
- 312.25
- 24830.8
- Krishna Instit Of Medical Scienc
- 614.65
- 21.15
- 3.56
- 674
- 350.02
- 24594.54
- Dr. Lal Pathlabs
- 2701.35
- 34.4
- 1.29
- 3645
- 2168.8
- 22581.05
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Narayana Hrudayalaya
- 43.5
- 12.05
- 23.44
- 9.72
- Global Health
- 71.43
- 11.74
- -
- -
- Aster Dm Healthcare
- 203.55
- 5.46
- 6.24
- 4.26
- Krishna Instit Of Medical Scienc
- 79.64
- 13.5
- 22.79
- 15.53
- Dr. Lal Pathlabs
- 62.84
- 12.16
- 21.32
- 15.99
Aster Dm Healthcare Shareholding
Shareholding Pattern
*Promoter pledging: 41.41%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 31-Jan-25
- Quarterly Results & Interim Dividend
- 23-Oct-24
- Quarterly Results
- 31-Jul-24
- Quarterly Results
- 28-May-24
- Audited Results & Final Dividend
- 12-Apr-24
- Interim Dividend & Special Dividend
- 08-Feb-24
- Quarterly Results
- 14-Nov-23
- Quarterly Results
- 14-Aug-23
- Quarterly Results
- 25-May-23
- Audited Results
- 14-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 31-Dec-24
- 02-Dec-24
- POM
- 24-Jan-24
- 26-Dec-23
- POM
- 31-Aug-23
- 25-May-23
- AGM
- 10-Apr-23
- 09-Mar-23
- POM
- 25-Aug-22
- 24-May-22
- AGM
- 22-Mar-22
- 16-Feb-22
- POM
- 13-Aug-21
- 24-Jun-21
- AGM
- -
- 28-May-24
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 27-Jan-25
- 10-Feb-25
- 10-Feb-25
- 4
- 28-May-24
- 22-Aug-24
- 22-Aug-24
- 2
- 05-Apr-24
- 23-Apr-24
- 23-Apr-24
- 118


